Health care resource utilization and characteristics of patients with eosinophilic asthma in secondary health care in Finland

References

• Bousquet J, Kaltaev N. Global surveillance. Prevention and control of chronic respiratory diseases: a comprehensive approach. Geneva, Switzerland: WHO; 2007.
   Google Scholar
• Kauppi P. Has asthma in adulthood changed? Finnish Med J. 2015;25:1811–8.
   Google Scholar
• Selroos O, Kupczyk M, Kuna P, et al. National and regional asthma programmes in Europe. Eur Respir Rev. 2015 Sep;24(137):474–483. PubMed PMID: 26324809.
   PubMed Web of Science ®Google Scholar
• Haahtela T, Herse F, Karjalainen J, et al. The Finnish experience to save asthma costs by improving care in 1987–2013. J Allergy Clin Immunol. 2017 Feb;139(2):408–414 e2. PubMed PMID: 27979429.
   Web of Science ®Google Scholar
• Jousilahti P, Haahtela T, Laatikainen T, et al. Asthma and respiratory allergy prevalence is still increasing among Finnish young adults. Eur Respir J. 2016 Mar;47(3):985–987. PubMed PMID: 26677942.
   Web of Science ®Google Scholar
• Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014 Feb;43(2):343–373. PubMed PMID: 24337046.
   PubMed Web of Science ®Google Scholar
• Chanez P, Wenzel SE, Anderson GP, et al. Severe asthma in adults: what are the important questions? J Allergy Clin Immunol. 2007 Jun;119(6):1337–1348. PubMed PMID: 17416409; eng.
   PubMed Web of Science ®Google Scholar
• Bahadori K, Doyle-Waters MM, Marra C, et al. Economic burden of asthma: a systematic review. BMC Pulm Med. 2009 May 19;9:24.
   PubMedGoogle Scholar
• Walsh CJ, Zaihra T, Benedetti A, et al. Exacerbation risk in severe asthma is stratified by inflammatory phenotype using longitudinal measures of sputum eosinophils. Clin Exp Allergy. 2016 Oct;46(10):1291–1302. PubMed PMID: 27214328.
   Web of Science ®Google Scholar
• Ulrik CS. Peripheral eosinophil counts as a marker of disease activity in intrinsic and extrinsic asthma. Clin Exp Allergy. 1995 Sep;25(9):820–827. PubMed PMID: 8564720; eng.
   PubMed Web of Science ®Google Scholar
• Bousquet J, Chanez P, Lacoste JY, et al. Eosinophilic inflammation in asthma. N Engl J Med. 1990 Oct 11;323(15):1033–1039. PubMed PMID: 2215562.
   PubMed Web of Science ®Google Scholar
• Zhang JY, Wenzel SE. Tissue and BAL based biomarkers in asthma. Immunol Allergy Clin North Am. 2007 Nov;27(4):623–632; vi. PubMed PMID: 17996580.
   Web of Science ®Google Scholar
• Casciano J, Krishnan JA, Small MB, et al. Value of peripheral blood eosinophil markers to predict severity of asthma. BMC Pulm Med. 2016 Jul 29;16(1):109. PubMed PMID: 27473851; PubMed Central PMCID: PMCPMC4966857.
   PubMedGoogle Scholar
• Louis R, Lau LC, Bron AO, et al. The relationship between airways inflammation and asthma severity. Am J Respir Crit Care Med. 2000 Jan;161(1):9–16. PubMed PMID: 10619791.
   PubMed Web of Science ®Google Scholar
• Horn BR, Robin ED, Theodore J, et al. Total eosinophil counts in the management of bronchial asthma. New England J Med. 1975;292(22):1152–1155. PubMed PMID: 1124105.
   PubMed Web of Science ®Google Scholar
• Broekema M, Volbeda F, Timens W, et al. Airway eosinophilia in remission and progression of asthma: accumulation with a fast decline of FEV(1). Respir Med. 2010 Sep;104(9):1254–1262. PubMed PMID: 20434897.
   Web of Science ®Google Scholar
• Tran TN, Khatry DB, Ke X, et al. High blood eosinophil count is associated with more frequent asthma attacks in asthma patients. Ann Allergy Asthma Immunol. 2014 Jul;113(1):19–24. PubMed PMID: 24846699.
   PubMed Web of Science ®Google Scholar
• Price D, Wilson AM, Chisholm A, et al. Predicting frequent asthma exacerbations using blood eosinophil count and other patient data routinely available in clinical practice. J Asthma Allergy. 2016;9:1–12. PubMed PMID: 26793004; PubMed Central PMCID: PMC4708874.
   PubMed Web of Science ®Google Scholar
• Malinovschi A, Fonseca JA, Jacinto T, et al. Exhaled nitric oxide levels and blood eosinophil counts independently associate with wheeze and asthma events in National Health and Nutrition Examination Survey subjects. J Allergy Clin Immunol. 2013 Oct;132(4):821–7 e1–5. PubMed PMID: 23890753.
   Web of Science ®Google Scholar
• Zeiger RS, Schatz M, Li Q, et al. High blood eosinophil count is a risk factor for future asthma exacerbations in adult persistent asthma. J Allergy Clin Immunology: In Pract. 2014;2(6):741–750.e4.
   Web of Science ®Google Scholar
• Price DB, Rigazio A, Campbell JD, et al. Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study. Lancet Respir Med. 2015 Nov;3(11):849–858. PubMed PMID: 26493938.
   PubMed Web of Science ®Google Scholar
• Casciano J, Krishnan JA, Small MB, et al. Burden of asthma with elevated blood eosinophil levels. BMC Pulm Med. 2016 Jul 13;16(1):100. PubMed PMID: 27412347; PubMed Central PMCID: PMC4944449.
   PubMedGoogle Scholar
• Casciano J, Krishnan J, Dotiwala Z, et al. Clinical and economic burden of elevated blood eosinophils in patients with and without uncontrolled asthma. Journal of Managed Care & Specialty Pharmacy. 2017 Jan;23(1):85–91. PubMed PMID: 28025926.
   Web of Science ®Google Scholar
• Amelink M, Hashimoto S, Spinhoven P, et al. Anxiety, depression and personality traits in severe, prednisone-dependent asthma. Respir Med. 2014 Mar;108(3):438–444. PubMed PMID: 24462260.
   Web of Science ®Google Scholar
• Iribarren C, Tolstykh IV, Miller MK, et al. Adult asthma and risk of coronary heart disease, cerebrovascular disease, and heart failure: a prospective study of 2 matched cohorts. Am J Epidemiol. 2012 Dec 01;176(11):1014–1024. PubMed PMID: 23139248.
   PubMed Web of Science ®Google Scholar
• Zazzali JL, Broder MS, Omachi TA, et al. Risk of corticosteroid-related adverse events in asthma patients with high oral corticosteroid use. Allergy Asthma Proc. 2015 Jul-Aug;36(4):268–274. PubMed PMID: 26108084.
   PubMed Web of Science ®Google Scholar
• Wang F-P, Liu T, Lan Z, et al. Efficacy and safety of anti-interleukin-5 therapy in patients with asthma: a systematic review and meta-analysis. Plos One. 2016;11(11):e0166833.
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383.
   PubMedGoogle Scholar
• Tykslab. Ex-Eosinofiilit [ cited 2017 22–08]. Available from: http://webohjekirja.mylabservices.fi/TYKS/index.php?test=1331
   Google Scholar
• Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention; 2017. Available from: www.ginasthma.org
   Google Scholar
• Parameswaran K, Pizzichini E, Pizzichini MM, et al. Clinical judgement of airway inflammation versus sputum cell counts in patients with asthma. Eur Respir J. 2000 Mar;15(3):486–490. PubMed PMID: 10759441.
   Web of Science ®Google Scholar
• Coumou H, Bel EH. Improving the diagnosis of eosinophilic asthma. Expert Rev Respir Med. 2016;10(10):1093–1103.
   PubMed Web of Science ®Google Scholar
• Green RH, Brightling CE, McKenna S, et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet. 2002 Nov 30;360(9347):1715–1721. PubMed PMID: 12480423.
   PubMed Web of Science ®Google Scholar
• Possa SS, Leick EA, Prado CM, et al. Eosinophilic inflammation in allergic asthma. Front Pharmacol. 2013;4:46. PubMed PMID: 23616768; PubMed Central PMCID: PMCPMC3627984.
   PubMed Web of Science ®Google Scholar
• Spahn JD. Asthma biomarkers in sputum. Immunol Allergy Clin North Am. 2012 Aug;32(3):387–399. PubMed PMID: 22877617.
   Web of Science ®Google Scholar
• Leynaert B, Bousquet J, Neukirch C, et al. Perennial rhinitis: an independent risk factor for asthma in nonatopic subjects: results from the European Community Respiratory Health Survey. J Allergy Clin Immunol. 1999 Aug;104(2 Pt 1):301–304. PubMed PMID: 10452748.
   Web of Science ®Google Scholar
• Passalacqua G, Ciprandi G, Canonica GW. United airways disease: therapeutic aspects. Thorax. 2000 Oct;55(Suppl 2):S26–S27. PubMed PMID: 10992552; PubMed Central PMCID: PMCPMC1765974.
   PubMed Web of Science ®Google Scholar
• Gershon AS, Wang C, Guan J, et al. Burden of comorbidity in individuals with asthma. Thorax. 2010 Jul;65(7):612–618. PubMed PMID: 20627918.
   Web of Science ®Google Scholar
• Steppuhn H, Langen U, Keil T, et al. Chronic disease co-morbidity of asthma and unscheduled asthma care among adults: results of the national telephone health interview survey German Health Update (GEDA) 2009 and 2010. Prim Care Respir J. 2014 Mar;23(1):22–29. PubMed PMID: 24346826.
   Google Scholar
• Wijnhoven HA, Kriegsman DM, Hesselink AE, et al. The influence of co-morbidity on health-related quality of life in asthma and COPD patients. Respir Med. 2003 May;97(5):468–475. PubMed PMID: 12735662.
   PubMed Web of Science ®Google Scholar
• Katz LE, Gleich GJ, Hartley BF, et al. Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthma. Ann Am Thorac Soc. 2014;11(4):531–536. PubMed PMID: 24606022.
   PubMedGoogle Scholar
• Mathur SK, Fichtinger PS, Evans MD, et al. Variability of blood eosinophil count as an asthma biomarker. Ann Allergy Asthma Immunol. 2016 Nov;117(5):551–553. PubMed PMID: 27590639; PubMed Central PMCID: PMCPMC5085834.
   Web of Science ®Google Scholar
• Spector SL, Tan RA. Is a single blood eosinophil count a reliable marker for “eosinophilic asthma?”. J Asthma. 2012 Oct;49(8):807–810. PubMed PMID: 22900679.
   PubMed Web of Science ®Google Scholar
• Matsunaga K, Hirano T, Akamatsu K, et al. Predictors for identifying the efficacy of systemic steroids on sustained exhaled nitric oxide elevation in severe asthma. Allergol Int. 2013 Sep;62(3):359–365. PubMed PMID: 23880612.
   PubMed Web of Science ®Google Scholar